123 related articles for article (PubMed ID: 7037067)
1. Differential role of fractionated heparin in antithrombin-III proteolysis.
Marciniak E
Blood; 1982 Mar; 59(3):576-81. PubMed ID: 7037067
[TBL] [Abstract][Full Text] [Related]
2. Enhancement by heparin of thrombin-induced antithrombin III proteolysis: its relation to the molecular weight and anticoagulant activity of heparin.
Marciniak E; Gora-Maslak G
Thromb Res; 1982 Nov; 28(3):411-21. PubMed ID: 7179225
[TBL] [Abstract][Full Text] [Related]
3. Thrombin-induced proteolysis of human antithrombin III: an outstanding contribution of heparin.
Marciniak E
Br J Haematol; 1981 Jun; 48(2):325-36. PubMed ID: 7236529
[TBL] [Abstract][Full Text] [Related]
4. The interaction of immobilized thrombin with human antithrombin III.
Marciniak E; Gora-Maslak G
Thromb Haemost; 1984 Feb; 51(1):27-31. PubMed ID: 6719385
[TBL] [Abstract][Full Text] [Related]
5. Dependence of antithrombin III and thrombin binding stoichiometries and catalytic activity on the molecular weight of affinity-purified heparin.
Nesheim M; Blackburn MN; Lawler CM; Mann KG
J Biol Chem; 1986 Mar; 261(7):3214-21. PubMed ID: 3949769
[TBL] [Abstract][Full Text] [Related]
6. Heparin and ionic strength-dependent conversion of antithrombin III from an inhibitor to a substrate of alpha-thrombin.
Olson ST
J Biol Chem; 1985 Aug; 260(18):10153-60. PubMed ID: 4019506
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
Nagasawa K; Uchiyama H
J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
[TBL] [Abstract][Full Text] [Related]
8. Dependence of the rate of thrombin/antithrombin III reaction upon the turnover rate of a catalytic amount of heparin.
Oshima G
Chem Pharm Bull (Tokyo); 1989 Aug; 37(8):2155-9. PubMed ID: 2598315
[TBL] [Abstract][Full Text] [Related]
9. Effects of heparin fractions of different affinities to antithrombin III and thrombin on the inactivation of thrombin and factor Xa by antithrombin III.
Cerskus AL; Birchall KJ; Ofosu FA; Hirsh J; Blajchman MA
Can J Biochem Cell Biol; 1984 Oct; 62(10):975-83. PubMed ID: 6509363
[TBL] [Abstract][Full Text] [Related]
10. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.
Olson ST; Björk I; Sheffer R; Craig PA; Shore JD; Choay J
J Biol Chem; 1992 Jun; 267(18):12528-38. PubMed ID: 1618758
[TBL] [Abstract][Full Text] [Related]
11. Reactivity of heparin with the human plasma heparin-binding proteins thrombin, antithrombin III, and apolipoproteins E and B-100.
Cardin AD; Barnhart RL; Witt KR; Jackson RL
Thromb Res; 1984 Jun; 34(6):541-50. PubMed ID: 6740570
[TBL] [Abstract][Full Text] [Related]
12. Enzymatic inactivation of human antithrombin III. Limited proteolysis of the inhibitor by snake venom proteinases in the presence of heparin.
Kress LF; Catanese J
Biochim Biophys Acta; 1980 Sep; 615(1):178-86. PubMed ID: 7426659
[TBL] [Abstract][Full Text] [Related]
13. Action of heparin on thrombin-antithrombin reaction.
Machovich R; Blaskó G; Pálos LA
Biochim Biophys Acta; 1975 Jan; 379(1):193-200. PubMed ID: 1115795
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
Jørgensen M; Petersen LC; Thorsen S
J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of rat skin heparin chains with high affinity for antithrombin.
Horner AA
Biochem J; 1987 Jun; 244(3):693-8. PubMed ID: 3446185
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory activities for thrombin and factor Xa of whale heparin: comparative studies on two preparations from different species.
Ototani N; Yosizawa Z
Tohoku J Exp Med; 1986 Sep; 150(1):77-82. PubMed ID: 3775773
[TBL] [Abstract][Full Text] [Related]
17. Asymmetric distribution of sites with high affinity for antithrombin III in rat skin heparin proteoglycans.
Horner AA; Young E
J Biol Chem; 1982 Aug; 257(15):8749-54. PubMed ID: 7096332
[TBL] [Abstract][Full Text] [Related]
18. Antithrombin BM from human plasma: an antithrombin binding moderately to heparin.
Wunderwald P; Schrenk WJ; Port H
Thromb Res; 1982 Feb; 25(3):177-91. PubMed ID: 6175043
[TBL] [Abstract][Full Text] [Related]
19. Behavior of antithrombin III isoforms on immobilized heparins. Evidence that the isoforms bind to different numbers of low-affinity heparin sites.
Carlson TH; Babcock T; Atencio AC; Levinson C; Mora HR
J Biol Chem; 1988 Feb; 263(5):2187-94. PubMed ID: 3339006
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies against antithrombin III. Identification of their epitopes and effects on antithrombin III activities.
Knoller S; Savion N
Eur J Biochem; 1989 Mar; 180(2):319-26. PubMed ID: 2466666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
